Study Summary
The proposed clinical trial is a double-blind, randomized controlled study with direct intramuscular injection of rAAVrh.74.MHCK7.DYSF.DV gene vector to the extensor digitorum brevis muscle (EDB). Two cohorts of subjects with dysferlin deficiency, each with proven mutations will undergo gene transfer. A minimum of three subjects will be enrolled into each cohort.
Want to learn more about this trial?
Request More InfoInterventions
rAAVrh74.MHCK7.DYSF.DVDRUG
Biological/Vaccine: rAAVrh74.MHCK7.DYSF.DV Recombinant adeno-associated virus carrying a dysferlin transgene under control of a muscle specific MHCK7 promoter.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Nationwide Children's Hosptial | Columbus | Ohio | United States |